BIOS
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
BIOS
Delisted
BIOS was delisted on the 6th of October, 2023.
61 hedge funds and large institutions have $231M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
61
Holding in Top 10
–
Calls
$104K
Puts
–
Top Buyers
| 1 | +$11.9M | |
| 2 | +$10.4M | |
| 3 | +$9.49M | |
| 4 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$9.08M |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$7.97M |
Top Sellers
| 1 | -$15.2M | |
| 2 | -$10.4M | |
| 3 | -$7.83M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$5.16M |
| 5 |
TCA
Taconic Capital Advisors
New York
|
-$5.14M |